This is consistent with evidence of a low level of p53 stabilization without activation of downstream protein MDM2 in TP53WT (without del17p) but SF3B1MUT CLL primary samples treated with increasing concentrations of RG7388 (Figure 4A,E). Here, TP53 is linked to B-cell chronic lymphocytic leukemia.